“The U.K. life science sector needs to be able to speak with one voice, wherever it goes, and present a united front,” Fear stresses. “However, the manner in which key information is communicated will need to be tailored to individual countries. The U.S. industry and financial sectors may already be well-informed about the U.K.’s life science industries, but in China or India, for example, U.K. companies may need to introduce themselves in a completely different way.
“Also, who delivers that message will depend on the country,” Fear continues. “In the U.S., for example, potential partners may be more inclined to listen to a business or entrepreneurial voice. In China or Japan, a U.K. governmental voice may hold more sway.
“This information will be available through the development of a comprehensive tool kit encompassing relevant messages, case-studies, industry data guides to countries, and customer analyses. The tool kit will allow any U.K. life science company, from the largest pharma to the smallest biotech, to access and take the most relevant messages with them in terms of U.K. innovation, support industry, tax incentives, and academic background.”
The board also aims to carry out a series of high-impact events, ranging from major international roadshows to one-on-one meetings with high-level board members or an ambassador from the U.K.
UKTI and the Strategy Implementation Board hope that executing and further developing the U.K. life science market over the next five years will significantly boost the country’s standing within the international arena, increase inward investments, business, and collaborations, as well as make the U.K. industry a more cohesive force.
The organization invites everyone in the life sciences industry, both in the U.K. and internationally, to get involved with the UK Life Science Marketing Strategy. More details are available at www.marketinglifescience.co.uk.